This study is not affiliated with PCOS Challenge, Inc.
The announcement below is being provided for informational purposes only.

P.O.W.E.R. Study Seeking Women with Polycystic Ovary Syndrome (PCOS) in the United States

Receive up to $1,200 Monetary Compensation for Participation
See Below for Details and Eligibility Criteria

Study Title

The P.O.W.E.R. Study: Polycystic Ovary Syndrome Women Empowered Research

~1 in 3 women with PCOS make too much cortisol (the “stress” hormone) and male hormones
(DHEA, androstenedione and testosterone), and as a result, experience excess weight gain,
hair growth, acne, and irregular periods.

Study Description

Why is this study being done?

The purpose of The P.O.W.E.R. Study:

Identify the safest and most effective dose of tildacerfont, a once-daily investigational drug
Assess if tildacerfont is effective in reducing the production of hormones by the adrenal glands and help
improve the health of women with PCOS
Evaluate beneficial effects of tildacerfont, such as weight reduction

Is tildacerfont safe?

Tildacerfont is generally well-tolerated in healthy volunteers in 8 studies with over 230 people across 20 countries.

Eligibility Criteria

The main requirements are as follows:

Females between 18 to 40 years old
Diagnosed with Polycystic Ovary Syndrome (PCOS)
Not pregnant, breastfeeding, or trying to become pregnant in the next 6 months.
Not diagnosed with either congenital adrenal hyperplasia (CAH) or Cushing’s syndrome

Trial Site Locations

22 clinical trial sites are available across the United States

City, State
Los Angeles, CA
San Francisco, CA
New Haven, CT
Safety Harbor, FL
Saint Petersburg, FL
Saint Petersburg, FL
Miami, FL
West Palm Beach, FL
Winter Park, FL
Idaho Falls, ID
Wichita, KS
Fall River, MA
Quincy, MA
Baltimore, MD
Lancaster, NY
Cincinnati, OH
Cleveland, OH
Philadelphia, PA
Dallas, TX
Houston, TX
Morgan, WV

Estimated Time Commitment for Study Participants

The study will take about 5 months to complete with 5 or 6 clinic visits and 3 phone calls over the first 4 months.
There will be one clinic visit 4 weeks after the last dose of the investigational drug.

How to Participate

Complete the prescreening questionnaire.
Qualified participants will be contacted with additional details.

For Additional Information

Visit: https://sprucebio.com/Power

*Disclaimer

This study is not affiliated with PCOS Challenge, Inc. PCOS Challenge, Inc. does not recommend or endorse any specific studies, tests, physicians, products, procedures, opinions, or other information from third parties that may be mentioned on the PCOS Challenge websites. Any such mention is for information purposes only. Any third-party services, products and websites, including those offered by affiliates, sponsors and advertisers, which may be accessed through the PCOS Challenge websites are the sole responsibility of the third party who is offering the service, product or posting the website. PCOS Challenge, Inc. makes no warranty as to the accuracy of any information on third-party websites and accepts no liability for any claims, errors, and omissions or for any damage or injury to persons or property arising out of the use or operation of any services, products, materials, instructions, methods, ideas or procedures provided by third parties. Any offers, pricing, and/or promotions offered through the PCOS Challenge websites, affiliates, or any third party are subject to change without notice at the sole discretion of the party making the offer. Read Full Disclaimer.

P.O.W.E.R. Study

P.O.W.E.R. Study Seeking Women with Polycystic Ovary Syndrome (PCOS) in the United States

Receive up to $1,200 Monetary Compensation for Participation
See Below for Details and Eligibility Criteria

Study Title